{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,3,22]],"date-time":"2025-03-22T10:28:20Z","timestamp":1742639300827,"version":"3.37.3"},"reference-count":50,"publisher":"Public Library of Science (PLoS)","issue":"6","license":[{"start":{"date-parts":[[2017,6,14]],"date-time":"2017-06-14T00:00:00Z","timestamp":1497398400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100004332","name":"Seoul National University Hospital","doi-asserted-by":"publisher","award":["800-20140047"],"award-info":[{"award-number":["800-20140047"]}],"id":[{"id":"10.13039\/501100004332","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004332","name":"Seoul National University Hospital","doi-asserted-by":"publisher","award":["800-20140048"],"award-info":[{"award-number":["800-20140048"]}],"id":[{"id":"10.13039\/501100004332","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003725","name":"National Research Foundation of Korea","doi-asserted-by":"publisher","award":["2013R1A2A2A01007299"],"award-info":[{"award-number":["2013R1A2A2A01007299"]}],"id":[{"id":"10.13039\/501100003725","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0179094","type":"journal-article","created":{"date-parts":[[2017,6,14]],"date-time":"2017-06-14T13:38:56Z","timestamp":1497447536000},"page":"e0179094","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":2,"title":["Immunological dynamics associated with rapid virological response during the early phase of type I interferon therapy in patients with chronic hepatitis C"],"prefix":"10.1371","volume":"12","author":[{"given":"Jae-Won","family":"Lee","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Won","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eun-Kyung","family":"Kwon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuri","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hyun Mu","family":"Shin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dong-Hyun","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chan-Ki","family":"Min","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ji-Yeob","family":"Choi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Won-Woo","family":"Lee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Myung-Sik","family":"Choi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Byeong Gwan","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3673-6397","authenticated-orcid":true,"given":"Nam-Hyuk","family":"Cho","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"340","published-online":{"date-parts":[[2017,6,14]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1038\/nri3787","article-title":"Type I interferons in infectious disease","volume":"15","author":"F McNab","year":"2015","journal-title":"Nat Rev Immunol"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1038\/nri3806","article-title":"Regulation of antiviral T cell responses by type I interferons","volume":"15","author":"J Crouse","year":"2015","journal-title":"Nat Rev Immunol"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1002\/jlb.64.3.358","article-title":"Interferon-alpha and granulocyte-macrophage colony-stimulating factor differentiate peripheral blood monocytes into potent antigen-presenting cells","volume":"64","author":"RL Paquette","year":"1998","journal-title":"J Leukoc Biol"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"3022","DOI":"10.1182\/blood.V98.10.3022","article-title":"Expression of CCR-7, MIP-3beta, and Th-1 chemokines in type I IFN-induced monocyte-derived dendritic cells: importance for the rapid acquisition of potent migratory and functional activities","volume":"98","author":"S Parlato","year":"2001","journal-title":"Blood"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"1407","DOI":"10.1182\/blood-2011-06-363564","article-title":"IFN-alpha enhances cross-presentation in human dendritic cells by modulating antigen survival, endocytic routing, and processing","volume":"119","author":"F Spadaro","year":"2012","journal-title":"Blood"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"4279","DOI":"10.4049\/jimmunol.169.8.4279","article-title":"Coordinated and distinct roles for IFN-alpha beta, IL-12, and IL-15 regulation of NK cell responses to viral infection","volume":"169","author":"KB Nguyen","year":"2002","journal-title":"J Immunol"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"1655","DOI":"10.1084\/jem.178.5.1655","article-title":"Interferon-Alpha Increases the Frequency of Interferon-Gamma-Producing Human Cd4+ T-Cells","volume":"178","author":"V Brinkmann","year":"1993","journal-title":"J Exp Med"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"3864","DOI":"10.1038\/ncomms4864","article-title":"Pathogenic potential of interferon alphabeta in acute influenza infection","volume":"5","author":"S Davidson","year":"2014","journal-title":"Nat Commun"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1126\/science.1235214","article-title":"Persistent LCMV Infection Is Controlled by Blockade of Type I Interferon Signaling","volume":"340","author":"JR Teijaro","year":"2013","journal-title":"Science"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1126\/science.1235208","article-title":"Blockade of chronic type I interferon signaling to control persistent LCMV infection","volume":"340","author":"EB Wilson","year":"2013","journal-title":"Science"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1172\/JCI89488","article-title":"Targeting type I interferon-mediated activation restores immune function in chronic HIV infection","volume":"127","author":"A Zhen","year":"2017","journal-title":"J Clin Invest"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"609","DOI":"10.3389\/fimmu.2016.00609","article-title":"Type-I Interferon Responses: From Friend to Foe in the Battle against Chronic Viral Infection","volume":"7","author":"A Murira","year":"2016","journal-title":"Front Immunol"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"2681","DOI":"10.4254\/wjh.v7.i26.2681","article-title":"Factors associated with the response to interferon-based antiviral therapies for chronic hepatitis C","volume":"7","author":"H Enomoto","year":"2015","journal-title":"World J Hepatol"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1093\/infdis\/jis663","article-title":"Pegylated Interferon alfa-2a monotherapy results in suppression of HIV type 1 replication and decreased cell-associated HIV DNA integration","volume":"207","author":"L Azzoni","year":"2013","journal-title":"J Infect Dis"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1038\/nrc.2016.14","article-title":"Antitumour actions of interferons: implications for cancer therapy","volume":"16","author":"BS Parker","year":"2016","journal-title":"Nat Rev Cancer"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1002\/hep.26300","article-title":"Postoperative Peg-Interferon Plus Ribavirin Is Associated With Reduced Recurrence of Hepatitis C Virus-Related Hepatocellular Carcinoma","volume":"58","author":"YC Hsu","year":"2013","journal-title":"Hepatol"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1016\/j.jhep.2016.04.008","article-title":"Unexpected high rate of early tumor recurrence in patients with HCV-related HCC undergoing interferon-free therapy","volume":"65","author":"M Reig","year":"2016","journal-title":"J Hepatol"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1038\/nri3581","article-title":"Regulation of type I interferon responses","volume":"14","author":"LB Ivashkiv","year":"2014","journal-title":"Nat Rev Immunol"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1186\/1743-422X-10-299","article-title":"Role of viral and host factors in interferon based therapy of hepatitis C virus infection","volume":"10","author":"M Imran","year":"2013","journal-title":"Virol J"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1038\/nri.2016.69","article-title":"Immune responses and immunopathology in acute and chronic viral hepatitis","volume":"16","author":"EC Shin","year":"2016","journal-title":"Nat Rev Immunol"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1111\/j.1440-1746.2011.06782.x","article-title":"Th17 cells are increased with severity of liver inflammation in patients with chronic hepatitis C","volume":"27","author":"Q Chang","year":"2012","journal-title":"J Gastroenterol Hepatol"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1159\/000369902","article-title":"The Role of Interferon-lambda Locus Polymorphisms in Hepatitis C and Other Infectious Diseases","volume":"7","author":"SJ Griffiths","year":"2015","journal-title":"J Innate Immun"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"792","DOI":"10.3904\/kjim.2015.30.6.792","article-title":"Incidence of and risk factors for thyroid dysfunction during peginterferon alpha and ribavirin treatment in patients with chronic hepatitis C","volume":"30","author":"Y Hwang","year":"2015","journal-title":"Korean J Intern Med"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1097\/MCG.0000000000000215","article-title":"Prospective Comparison of Noninvasive Fibrosis Assessment to Predict Advanced Fibrosis or Cirrhosis in Asian Patients With Hepatitis C","volume":"49","author":"SK Joo","year":"2015","journal-title":"J Clin Gastroenterol"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1159\/000369902","article-title":"The Role of Interferon-lambda Locus Polymorphisms in Hepatitis C and Other Infectious Diseases","volume":"7","author":"SJ Griffiths","year":"2015","journal-title":"J Innate Immun"},{"key":"ref26","first-page":"84","article-title":"Increased Th1, Th17 and pro-fibrotic responses in hepatitis C-infected patients are down-regulated after 12 weeks of treatment with pegylated interferon plus ribavirin","volume":"21","author":"MA Jimenez-Sousa","year":"2010","journal-title":"Eur Cytokine Netw"},{"key":"ref27","article-title":"Wang R et al. (2016) Involvement of the Interleukin-23\/Interleukin-17 Axis in Chronic Hepatitis C Virus Infection and Its Treatment Responses","volume":"17","author":"P Meng","journal-title":"Int J Mol Sci"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1111\/imm.12330","article-title":"Imbalance of regulatory T cells and T helper type 17 cells in patients with chronic hepatitis C","volume":"143","author":"C Hao","year":"2014","journal-title":"Immunol"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"1537","DOI":"10.1007\/s12272-016-0823-8","article-title":"Targeting IL-17 in autoimmunity and inflammation","volume":"39","author":"BS Kim","year":"2016","journal-title":"Arch Pharm Res"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1016\/j.molmed.2016.01.001","article-title":"IL-17 in Chronic Inflammation: From Discovery to Targeting","volume":"22","author":"A Beringer","year":"2016","journal-title":"Trends Mol Med"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1016\/j.jhep.2005.04.009","article-title":"Predicting sustained virological responses in chronic hepatitis C patients treated with peginterferon alfa-2a (40 KD)\/ribavirin","volume":"43","author":"P Ferenci","year":"2005","journal-title":"J Hepatol"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1053\/jhep.2003.50350","article-title":"High body mass index is an independent risk factor for nonresponse to antiviral treatment in chronic hepatitis C","volume":"38","author":"BL Bressler","year":"2003","journal-title":"Hepatol"},{"key":"ref33","doi-asserted-by":"crossref","first-page":"8678","DOI":"10.3748\/wjg.v19.i46.8678","article-title":"Alanine aminotransferase normalization at week 8 predicts viral response during hepatitis C treatment","volume":"19","author":"UB Dogan","year":"2013","journal-title":"World J Gastroenterol"},{"key":"ref34","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1097\/MCG.0b013e3182896abf","article-title":"Role of interleukin 28B-related gene polymorphisms in chronic hepatitis C and the response to antiviral therapy in Koreans","volume":"47","author":"YK Jung","year":"2013","journal-title":"J Clin Gastroenterol"},{"key":"ref35","doi-asserted-by":"crossref","first-page":"177","DOI":"10.3350\/cmh.2014.20.2.177","article-title":"No association between the IL28B SNP and response to peginterferon plus ribavirin combination treatment in Korean chronic hepatitis C patients","volume":"20","author":"NY Heo","year":"2014","journal-title":"Clin Mol Hepatol"},{"key":"ref36","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1038\/ng.2521","article-title":"A variant upstream of IFNL3 (IL28B) creating a new interferon gene IFNL4 is associated with impaired clearance of hepatitis C virus","volume":"45","author":"L Prokunina-Olsson","year":"2013","journal-title":"Nat Genet"},{"key":"ref37","doi-asserted-by":"crossref","first-page":"26","DOI":"10.3350\/cmh.2013.19.1.26","article-title":"Is peginterferon and ribavirin therapy effective in Korean patients with chronic hepatitis C?","volume":"19","author":"YK Jung","year":"2013","journal-title":"Clin Mol Hepatol"},{"key":"ref38","doi-asserted-by":"crossref","first-page":"1314","DOI":"10.1002\/hep.26128","article-title":"Hepatitis C virus promotes t-helper (Th)17 responses through thymic stromal lymphopoietin production by infected hepatocytes","volume":"57","author":"HC Lee","year":"2013","journal-title":"Hepatol"},{"key":"ref39","doi-asserted-by":"crossref","first-page":"132","DOI":"10.2174\/1874279301004010132","article-title":"Serum Serotonin Levels are Associated with Antiviral Therapy Outcomes in Patients with Chronic Hepatitis C","volume":"4","author":"JM Loftis","year":"2010","journal-title":"Open Infect Dis J"},{"key":"ref40","doi-asserted-by":"crossref","first-page":"1617","DOI":"10.1002\/hep.21407","article-title":"IP-10 predicts viral response and therapeutic outcome in difficult-to-treat patients with HCV genotype 1 infection","volume":"44","author":"M Lagging","year":"2006","journal-title":"Hepatol"},{"key":"ref41","doi-asserted-by":"crossref","first-page":"389","DOI":"10.4167\/jbv.2015.45.4.389","article-title":"Role of Th17 and Treg during the Chronic Infection of Hepatitis C Virus","volume":"45","author":"HM Shin","year":"2015","journal-title":"J Bacteriol Virol"},{"key":"ref42","article-title":"The Interplay between Zinc, Vitamin D and, IL-17 in Patients with Chronic Hepatitis C Liver Disease","author":"R Reda","year":"2015","journal-title":"J Immunol Res"},{"key":"ref43","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1016\/j.cyto.2012.06.003","article-title":"Serum levels of Th17 associated cytokines in chronic hepatitis C virus infection","volume":"60","author":"GM Sousa","year":"2012","journal-title":"Cytokine"},{"key":"ref44","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1086\/507307","article-title":"Interferon (IFN)-gamma-inducible protein-10: association with histological results, viral kinetics, and outcome during treatment with pegylated IFN-alpha 2a and ribavirin for chronic hepatitis C virus infection","volume":"194","author":"AI Romero","year":"2006","journal-title":"J Infect Dis"},{"key":"ref45","first-page":"A42","article-title":"The clinical significance of interferon inducible protein-10 in chronic hepatitis C patients with genotype I undergoing pegylated interferon and ribavirin therapy","volume":"23","author":"CH Kim","year":"2008","journal-title":"J Gastroenterol and Hepatol"},{"key":"ref46","doi-asserted-by":"crossref","first-page":"1166","DOI":"10.1002\/hep.26679","article-title":"Fibroblast growth factor signaling in liver carcinogenesis","volume":"59","author":"DS Sandhu","year":"2014","journal-title":"Hepatol"},{"key":"ref47","doi-asserted-by":"crossref","first-page":"871","DOI":"10.3349\/ymj.2011.52.6.871","article-title":"Clinical implications of chemokines in acute and chronic hepatitis C virus infection","volume":"52","author":"W Kang","year":"2011","journal-title":"Yonsei Med J"},{"key":"ref48","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1016\/j.autrev.2013.12.004","article-title":"Th17 and regulatory T cell balance in autoimmune and inflammatory diseases","volume":"13","author":"M Noack","year":"2014","journal-title":"Autoimmun Rev"},{"key":"ref49","doi-asserted-by":"crossref","first-page":"400","DOI":"10.3389\/fimmu.2014.00400","article-title":"Gamma Delta T-lymphocytes in Hepatitis C and Chronic Liver Disease","volume":"5","author":"N Rajoriya","year":"2014","journal-title":"Front Immunol"},{"key":"ref50","doi-asserted-by":"crossref","first-page":"3289","DOI":"10.4049\/jimmunol.1303281","article-title":"Intrahepatic Innate Lymphoid Cells Secrete IL-17A and IL-17F That Are Crucial for T Cell Priming in Viral Infection","volume":"192","author":"ZL Jie","year":"2014","journal-title":"J Immunol"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0179094","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,9,25]],"date-time":"2019-09-25T22:51:46Z","timestamp":1569451906000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0179094"}},"subtitle":[],"editor":[{"given":"Eui-Cheol","family":"Shin","sequence":"first","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2017,6,14]]},"references-count":50,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2017,6,14]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0179094","relation":{},"ISSN":["1932-6203"],"issn-type":[{"type":"electronic","value":"1932-6203"}],"subject":[],"published":{"date-parts":[[2017,6,14]]}}}